Miranda Hugo F, Noriega Viviana, Sierralta Fernando, Poblete Paula, Aranda Nicolas, Prieto Juan Carlos
Neuroscience Department, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Cardiovascular Department, Clinical Hospital, Universidad de Chile, Santiago, Chile.
Drug Res (Stuttg). 2019 Oct;69(10):572-578. doi: 10.1055/a-0956-673. Epub 2019 Jun 28.
The principal mechanism of action of non-steroidal anti-inflammatory drugs (NSAIDs) is the inhibition of ciclooxigenases. In this study was evaluated if NSAIDs could induce antinociceptive differences according to the type of murine pain model. Male mice were injected intraperitoneally with meloxicam, diclofenac, piroxicam, metamizol, ibuprofen, naproxen and paracetamol in the writhing, tail flick and formalin orofacial tests and dose-response were analyzed to obtain the ED of each drugs. Administration of NSAIDs produced in a dose-dependent antinociception with different potency in the tests. The relative potency of NSAIDs among the tests shows a value of 5.53 in the orofacial formalin test in phase I and 6.34 in phase II between meloxicam and paracetamol; of 7.60 in the writhing test between meloxicam and paracetamol and of 8.46 in the tail flick test between ibuprofen and paracetamol. If the comparison is made for each NSAID in the different tests, the minimum value was 0.01 for between writhing and phase II of the orofacial formalin. Meanwhile, the highest power ratio was 11.71 for diclofenac between writhing and tail flick tests. In conclusion, the results suggests that intraperitoneal NSAIDs administration induce antinociceptive activity depending on the type of pain. The results support that NSAIDs administration, induce a wide variety of antinociceptive effect, depending on the type of pain. This suggest the participation of different mechanisms of action that can be added to the simple inhibition of COXs controlled by NSAIDs.
非甾体抗炎药(NSAIDs)的主要作用机制是抑制环氧化酶。本研究评估了NSAIDs是否会根据小鼠疼痛模型的类型诱导不同的镇痛差异。在扭体、甩尾和福尔马林口腔测试中,给雄性小鼠腹腔注射美洛昔康、双氯芬酸、吡罗昔康、安乃近、布洛芬、萘普生和对乙酰氨基酚,并分析剂量反应以获得每种药物的半数有效剂量(ED)。NSAIDs的给药在测试中产生了剂量依赖性的镇痛作用,且效力不同。在I期口腔福尔马林测试中,美洛昔康和对乙酰氨基酚之间NSAIDs的相对效力值为5.53,在II期为6.34;在扭体测试中,美洛昔康和对乙酰氨基酚之间为7.60;在甩尾测试中,布洛芬和对乙酰氨基酚之间为8.46。如果在不同测试中对每种NSAIDs进行比较,扭体测试和口腔福尔马林II期之间的最小值为0.01。同时,双氯芬酸在扭体和甩尾测试之间的最高效力比为11.71。总之,结果表明腹腔注射NSAIDs会根据疼痛类型诱导镇痛活性。结果支持NSAIDs给药会根据疼痛类型诱导多种镇痛效果。这表明不同作用机制的参与,这些机制可能叠加在由NSAIDs控制的COXs简单抑制作用之上。